Andere Sprachen Longboard Pharmaceuticals, Inc.

Aktien

A2QQZ6

US54300N1037

LBPH

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 25.04.2024			% 5 Tage	% 1. Jan.
19,25 ^USD	-2,53 %		+6,89 %	+219,24 %

12.03.	Longboard Pharmaceuticals, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
16.01.	LONGBOARD PHARMACEUTICALS, INC. : Cantor Fitzgerald bekräftigt seine Kaufempfehlung	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

LONGBOARD PHARMACEUTICALS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(4)	03.04.
Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15	03.04.
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)	02.04.
Longboard Pharmaceuticals, Inc. announced that it has received $59.85 million in funding	26.03.
Longboard Pharmaceuticals, Inc.(NasdaqGM:LBPH) added to S&P Pharmaceuticals Select Industry Index	18.03.
Longboard Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	12.03.
Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates	12.03.
LONGBOARD PHARMACEUTICALS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(4)	04.03.
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)	01.03.
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)	02.02.
Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences in February	01.02.
LONGBOARD PHARMACEUTICALS ANNOUNCES CLOSING OF PUBLIC OFFERING OF COMMON STOCK AND FULL EXERCISE OF UNDERWRITERS OPTION TO PURCHASE ADDITIONAL SHARES	09.01.
Longboard Pharmaceuticals Closes $242 Million Public Offering	08.01.
Longboard Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares	08.01.
Longboard Pharmaceuticals Prices $210 Million Stock Offering	04.01.
Longboard Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock	04.01.
LONGBOARD PHARMACEUTICALS ANNOUNCES POSITIVE TOPLINE DATA FROM THE PACIFIC STUDY, A PHASE 1B/2A CLINICAL TRIAL, FOR BEXICASERIN IN PARTICIPANTS WITH DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHIES	03.01.
Longboard Pharmaceuticals Launching Share Offering	02.01.
Longboard Pharmaceuticals Announces Commencement of Public Offering of Common Stock	02.01.
Sector Update: Health Care Stocks Gain Late Afternoon	02.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Longboard Pharmaceuticals, Inc.

Aktien

A2QQZ6

US54300N1037

LBPH

Andere Sprachen

Filter